The International Traditional Medicine Clinical Trial Registry has joined the WHO Registry Network. It registers studies of traditional medicine from any country, including Chinese medicine and acupuncture, has editors specialising in traditional medicine and accepts submissions in either English or Chinese.
The ISRCTN registry is a primary clinical trial registry recognised by WHO and ICMJE that accepts all clinical research studies (whether proposed, ongoing or completed), providing content validation and curation and the unique identification number necessary for publication. All study records in the database are freely accessible and searchable.
ISRCTN supports transparency in clinical research, helps reduce selective reporting of results and ensures an unbiased and complete evidence base.
ISRCTN accepts all studies involving human subjects or populations with outcome measures assessing effects on human health and well-being, including studies in healthcare, social care, education, workplace safety and economic development. The registry welcomes submissions in English from any location. Studies should ideally be registered prospectively (before recruitment starts). ISRCTN also accepts studies registered retrospectively once they are underway or after completion.
Prevalence of coexisting autoimmune disorders among inflammatory bowel disease (IBD) patients at a tertiary care centre in Riyadh, Saudi Arabia: a cross-sectional study
A phase 3 multicentre, randomised, double-blind, placebo-controlled and deucravacitinib active comparator-controlled study to evaluate the efficacy and safety of JNJ-77242113 for the treatment of participants with moderate to severe plaque psoriasis - ICONIC-ADVANCE 1
Evaluation of a multicomponent intervention to improve perinatal bereavement support for women and families after stillbirth and neonatal death in Kenya and Uganda: a pragmatic cluster randomized controlled trial
.png)
.png)
